Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hamid Masoudi

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
Breast Cancer Research : BCR|October 18, 2008
Redefining prognostic factors for breast cancer: YB-1 is a stronger predictor of relapse and disease-specific survival than estrogen receptor or HER-2 across all tumor subtypesGolareh Habibi, Samuel Leung, Jennifer H Law, et al.
American Journal of Surgery|April 9, 2015
Prognostic significance of autocrine motility factor receptor expression by colorectal cancer and lymph node metastasesYasmin Halwani, Liliana D Kojic, Simon K Chan, et al.
Blood|June 4, 2005
Analysis of multiple biomarkers shows that lymphoma-associated macrophage (LAM) content is an independent predictor of survival in follicular lymphoma (FL)Pedro Farinha, Hamid Masoudi, Brian F Skinnider, et al.
American Journal of Surgery|March 10, 2012
Beta-catenin expression is prognostic of improved non-small cell lung cancer survivalConnie G Chiu, Simon K Chan, Z Amy Fang, et al.
Genes, Chromosomes & Cancer|December 21, 2004
beta-catenin (CTNNB1) gene amplification: a new mechanism of protein overexpression in cancerGianpaolo Suriano, Nikoleta Vrcelj, Janine Senz, et al.
Cancer Research|October 17, 2008
Phosphorylated caveolin-1 regulates Rho/ROCK-dependent focal adhesion dynamics and tumor cell migration and invasionBharat Joshi, Scott S Strugnell, Jacky G Goetz, et al.
Cancer Research|December 17, 2008
Phosphorylated insulin-like growth factor-i/insulin receptor is present in all breast cancer subtypes and is related to poor survivalJennifer H Law, Golareh Habibi, Kaiji Hu, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Breast Cancer Research : BCR|October 18, 2008
Redefining prognostic factors for breast cancer: YB-1 is a stronger predictor of relapse and disease-specific survival than estrogen receptor or HER-2 across all tumor subtypesGolareh Habibi, Samuel Leung, Jennifer H Law, et al.
American Journal of Surgery|April 9, 2015
Prognostic significance of autocrine motility factor receptor expression by colorectal cancer and lymph node metastasesYasmin Halwani, Liliana D Kojic, Simon K Chan, et al.
Blood|June 4, 2005
Analysis of multiple biomarkers shows that lymphoma-associated macrophage (LAM) content is an independent predictor of survival in follicular lymphoma (FL)Pedro Farinha, Hamid Masoudi, Brian F Skinnider, et al.
American Journal of Surgery|March 10, 2012
Beta-catenin expression is prognostic of improved non-small cell lung cancer survivalConnie G Chiu, Simon K Chan, Z Amy Fang, et al.
Genes, Chromosomes & Cancer|December 21, 2004
beta-catenin (CTNNB1) gene amplification: a new mechanism of protein overexpression in cancerGianpaolo Suriano, Nikoleta Vrcelj, Janine Senz, et al.
Cancer Research|October 17, 2008
Phosphorylated caveolin-1 regulates Rho/ROCK-dependent focal adhesion dynamics and tumor cell migration and invasionBharat Joshi, Scott S Strugnell, Jacky G Goetz, et al.
Cancer Research|December 17, 2008
Phosphorylated insulin-like growth factor-i/insulin receptor is present in all breast cancer subtypes and is related to poor survivalJennifer H Law, Golareh Habibi, Kaiji Hu, et al.
Pageof 3